デフォルト表紙
市場調査レポート
商品コード
1527179

採血市場：世界の産業規模、シェア、動向、機会、予測、採取部位別、用途別、方法別、最終用途別、地域別、競合別、2019-2029年

Blood Collection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Collection Site, By Application, By Method, By End-use, By Region and Competition, 2019-2029F

出版日
ページ情報
英文 180 Pages
納期
2～3営業日
カスタマイズ可能
採血市場：世界の産業規模、シェア、動向、機会、予測、採取部位別、用途別、方法別、最終用途別、地域別、競合別、2019-2029年
出版日: 2024年08月02日
発行: TechSci Research
ページ情報: 英文 180 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

採血の世界市場規模は2023年に92億6,000万米ドルとなり、2029年までのCAGRは6.07%で、予測期間中に目覚ましい成長が予測されています。

採血はヘルスケアインフラの重要なコンポーネントであり、治療、手術、外傷治療、疾病管理をサポートします。採血には、自発的な献血またはドナーからの医療による血液の採取が含まれます。採血された血液は、輸血のための安全性と適合性を確保するために綿密な検査が行われます。このプロセスは、手術や外傷治療から慢性疾患の管理やがん治療まで、さまざまな医療シーンに対応するために不可欠です。採血市場は、世界中で献血、処理、検査など幅広い活動を網羅しています。採血には、困っている人を助けるために血液を提供しようとする個人からの自発的な献血が含まれます。これらの献血者は個人または組織化されたグループであり、保管、分配のいずれかに貢献します。慢性疾患の患者は、特に難しい手術、透析、化学療法、臓器や組織の移植手術の際に、採血製品を使用して治療されます。手術は、日常的なものであれ複雑なものであれ、失われた血液を補い、酸素輸送を確保し、身体の治癒プロセスをサポートするために、しばしば輸血を必要とします。採血センターは、このような手術に必要な血液を供給します。採血市場は、全血または赤血球、血小板、血漿などの特定の血液成分の献血の増加の影響を強く受けています。採血産業は、血液と血液製剤の安全性と品質を確保するために、国内外の保健当局によって高度に規制されています。規制の枠組みは、ドナーの適格性基準、検査基準、保管条件、表示、輸送をカバーしています。

市場概要
予測期間 2026年～2030年
市場規模：2023年 92億6,000万米ドル
市場規模：2029年 131億3,000万米ドル
CAGR：2024年～2029年 6.07%
急成長セグメント 病院
最大市場 北米

市場促進要因

慢性疾患の増加に伴う血液需要の増加

医療介入の急増

技術革新の高まり

主な市場課題

十分な供給の維持

安全性と検査の保証

物流と流通の効率化

主な市場動向

持続可能で環境に優しいソリューション

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の採血市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 採取部位別（静脈{針と注射器、チューブ、血液バッグ、その他}、毛細血管{ランセット、マイクロコンテナチューブ、マイクロヘマトクリットチューブ、加温装置、その他}）
    • 用途別（診断、治療）
    • 方法別（手動、自動）
    • 最終用途別（病院、血液バンク、その他）
    • 企業別（2023年）
    • 地域別
  • 市場マップ

第6章 北米の採血市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 採取部位別
    • 用途別
    • 方法別
    • 最終用途別
    • 国別
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州の採血市場展望

  • 市場規模・予測
    • 金額・数量別
  • 市場シェア・予測
    • 採取部位別
    • 用途別
    • 方法別
    • 最終用途別
    • 国別
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域の採血市場展望

  • 市場規模・予測
    • 金額・数量別
  • 市場シェア・予測
    • 採取部位別
    • 用途別
    • 方法別
    • 最終用途別
    • 国別
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米の採血市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 採取部位別
    • 用途別
    • 方法別
    • 最終用途別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの採血市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 採取部位別
    • 用途別
    • 方法別
    • 最終用途別
    • 国別
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の動向
  • 製品上市
  • 合併と買収

第13章 PESTEL分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • NIPRO Medical Corporation
  • Abbott Laboratories Inc.
  • Becton, Dickinson and Company
  • Terumo Corporation
  • Qiagen N.V
  • Medtronic plc
  • FL Medical s.r.l.
  • SARSTEDT AG & Co. KG
  • Greiner Holding AG
  • Haemonetics Corporation

第16章 戦略的提言

第17章 調査会社について・免責事項

目次
Product Code: 23957

Global Blood Collection Market was valued at USD 9.26 billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.07% through 2029. Blood collection is a crucial component of the healthcare infrastructure, supporting medical treatments, surgeries, trauma care, and disease management. Blood collection involves the voluntary donation or medical extraction of blood from donors. Once collected, the blood undergoes meticulous testing to ensure its safety and compatibility for transfusion. This process is essential for addressing a range of medical scenarios, from surgeries and trauma care to managing chronic conditions and cancer treatments. The blood collection market encompasses a wide range of activities, including blood donation, processing, testing, across the globe. Blood collection includes voluntary blood donations from individuals who are willing to donate their blood to help others in need. These donors can be individuals or organized groups, and they contribute either storage, and distribution. Patients with chronic disorders are treated using blood collection products, notably during difficult surgeries, dialysis, chemotherapy, and organ or tissue transplant operations. Surgeries, both routine and complex, often require blood transfusions to replace blood loss, ensure oxygen transport, and support the body's healing process. Blood collection centers provide the necessary supply for such interventions. The blood collection market is highly influenced by the rise in blood donations whole blood or specific blood components such as red blood cells, platelets, plasma, etc. The blood collection industry is highly regulated by national and international health authorities to ensure the safety and quality of blood and blood products. Regulatory frameworks cover donor eligibility criteria, testing standards, storage conditions, labeling, and transportation.

Market Overview
Forecast Period2026-2030
Market Size 2023USD 9.26 Billion
Market Size 2029USD 13.13 Billion
CAGR 2024-20296.07%
Fastest Growing SegmentHospitals
Largest MarketNorth America

Key Market Drivers

Growing Demand of Blood in Increasing Chronic Disease Prevalence

The global blood collection market is witnessing a substantial surge in demand, driven significantly by the increasing prevalence of chronic diseases across the globe. Chronic diseases, characterized by their long-lasting and often progressive nature, encompass a wide range of conditions such as cardiovascular diseases, diabetes, cancer, and chronic respiratory diseases. This escalating burden of chronic diseases has a direct and profound impact on the demand for blood collection services and products. According to the World Health Organization (WHO), chronic diseases are the leading cause of mortality worldwide, accounting for approximately 71% of all deaths. The prevalence of chronic diseases is accelerating due to factors like aging populations, urbanization, unhealthy lifestyles, and genetic predisposition. The toll of chronic diseases is felt across all age groups and regions, making their effective management a critical healthcare priority. Many chronic diseases necessitate medical interventions that require blood transfusions. Surgeries, chemotherapy, radiation therapy, and interventions to manage complications often rely on a consistent supply of blood products. Certain chronic diseases, such as anemia in chronic kidney disease or leukemia in cancer patients, can lead to blood-related disorders. These disorders often require regular blood transfusions to manage symptoms and improve patients' quality of life. Chronic diseases can lead to unexpected complications that require emergency interventions, often involving blood transfusions.

Surge in Medical Interventions

Medical advancements have propelled the healthcare industry into new realms of precision and effectiveness. With a rising number of intricate medical interventions being performed worldwide, the demand for blood collection has soared to unprecedented heights. This symbiotic relationship between medical procedures and blood collection plays a pivotal role in ensuring successful outcomes for patients across various medical domains. The increasing prevalence of complex surgeries, organ transplants, and advanced treatments for conditions such as cancer and cardiovascular diseases has given rise to a greater need for blood collection. Blood, a vital source of life-sustaining components, serves multiple functions in modern healthcare. From providing oxygen and nutrients to tissues to facilitating the immune response, blood is an irreplaceable resource. Consequently, medical interventions that involve blood loss necessitate replenishing this crucial fluid to maintain patients' stability and recovery. Transfusions, a key component of medical care, rely heavily on blood collection. Patients undergoing surgeries, particularly those that involve extensive tissue manipulation, require blood transfusions to compensate for blood loss and optimize their chances of recovery. Similarly, individuals undergoing chemotherapy or radiation therapy often experience decreased red blood cell counts, prompting the need for blood transfusions to alleviate anemia and its associated symptoms. Emerging medical fields such as regenerative medicine and gene therapy are also contributing to the surge in blood collection demands. Stem cell transplants, a cornerstone of regenerative medicine, require donors and recipients to undergo thorough blood compatibility testing. Similarly, gene therapy, which holds promising potential in treating genetic disorders, requires meticulous monitoring of patients' blood parameters to ensure the effectiveness and safety of the treatment. As the demand for blood collection continues to rise, the importance of efficient blood management cannot be overstated. Blood banks and donation centers play a pivotal role in ensuring a steady supply of safe and compatible blood products. Additionally, advancements in blood storage and preservation techniques have extended the shelf life of collected blood, allowing healthcare providers more flexibility in managing their inventory.

Rising Technological Innovations

In healthcare, technological innovations have emerged as a significant driver behind the increased demand for blood collection. These innovations, ranging from advanced medical procedures to cutting-edge diagnostic tools, have reshaped the way medical interventions are performed and consequently amplified the necessity for efficient blood collection. One significant technological advancement that has bolstered the demand for blood collection is the rise of minimally invasive surgeries. Procedures once requiring large incisions have been replaced by less intrusive techniques, resulting in reduced patient trauma and quicker recovery times. However, these minimally invasive surgeries can still lead to blood loss, albeit on a smaller scale. Consequently, the demand for blood collection, even in these less invasive procedures, remains crucial to ensure patients' well-being during and after surgery. Additionally, diagnostic technologies have also played a pivotal role in increasing blood collection demand. The advent of precision medicine and personalized diagnostics has led to a greater emphasis on early disease detection and targeted treatments. Biomarker analysis, which often involves blood testing, provides valuable insights into a patient's health status and aids in tailoring treatment plans. As a result, the need for blood collection to facilitate these diagnostic endeavors has grown significantly. The development of advanced treatments such as immunotherapies and gene therapies has further propelled the demand for blood collection. These revolutionary treatments require comprehensive patient profiling and ongoing monitoring of blood parameters to ensure their effectiveness and safety. Blood samples offer valuable information about a patient's immune response, genetic makeup, and overall health, making them indispensable in the management of these novel therapeutic approaches. Telemedicine and remote patient monitoring have also contributed to the surge in blood collection demand. With the ability to remotely track patients' health conditions, healthcare providers can identify potential issues early on and initiate appropriate interventions. Blood samples collected at local clinics or even at patients' homes can be swiftly analyzed, allowing for timely adjustments to treatment plans.

Key Market Challenges

Sustaining Adequate Supply

Ensuring a consistent and sufficient supply of blood remains a paramount challenge for the global blood collection industry. Factors such as seasonal variations, emergencies, and evolving donor demographics can lead to periodic shortages. The industry grapples with fluctuating supplies caused by factors like seasonal shifts and unforeseen emergencies. These variations can result in periodic shortages, straining the availability of critical blood products. Ensuring a reliable supply chain that can swiftly adapt to these dynamics remains a significant challenge, demanding proactive strategies to anticipate and address shortages promptly. Encouraging regular voluntary donations, particularly in regions with cultural or logistical barriers, poses a constant challenge. Maintaining a diverse and committed donor pool to meet the diverse needs of patients and medical procedures requires ongoing efforts and innovative strategies.

Safety and Testing Assurance

Maintaining the safety and quality of donated blood is a critical challenge. Stringent testing protocols are essential to identify infectious agents and ensure compatibility. However, new pathogens and emerging diseases continuously pose challenges to existing testing methods. Striking a balance between stringent testing procedures and the urgent need for timely availability is a complex challenge. Emerging diseases and the appearance of previously unidentified infectious agents necessitate constant vigilance. The adaptability of these pathogens calls for a dynamic approach to testing and safety measures. Blood collection centers must remain agile, prepared to integrate new testing technologies and protocols to effectively screen for these emerging threats. Ensuring donor and recipient safety while mitigating the risk of transmitting infections remains a constant focus for blood collection centers worldwide. Implementing stringent protocols, updating practices in response to emerging threats, and fostering a culture of awareness among donors and staff are pivotal.

Logistics and Distribution Efficiency

Efficient transportation and distribution networks are essential to deliver blood products promptly to medical facilities. However, logistical challenges such as transportation delays, infrastructure limitations, and remote area accessibility hinder timely distribution. Maintaining temperature-controlled conditions to preserve the quality of blood products during transit presents logistical complexities. Maintaining temperature-controlled conditions throughout the journey is paramount to safeguarding the viability and integrity of blood components. Coordinating with multiple stakeholders, including blood banks, hospitals, and transportation providers, requires meticulous planning and continuous monitoring to optimize distribution efficiency. Continuous monitoring, tracking, and analysis of distribution processes are necessary to identify loopholes, enhance performance, and respond to unforeseen challenges. The optimization of distribution efficiency demands a proactive approach that relies on real-time data and feedback loops.

Key Market Trends

Sustainable and Eco-Friendly Solutions

Advances in genomics and personalized medicine are tailoring healthcare treatments to individual patients. This trend is extending to blood collection, with a focus on providing blood products that match patients' genetic profiles. Precise compatibility reduces the risk of adverse reactions, making personalized blood products an emerging area of growth. This transformative trend is not only revolutionizing treatment approaches but is also extending its influence on the blood collection sector. By leveraging genetic insights, blood collection is venturing into a realm of precision by offering blood products that align with individual patients' genetic profiles. This innovative approach is poised to redefine compatibility, safety, and patient outcomes in the realm of blood transfusions. Advances in genomics now allow for a deeper understanding of a patient's genetic makeup, paving the way for more precise compatibility assessments. By analyzing specific genetic markers related to blood compatibility, personalized blood products can be tailored to match the recipient's unique genetic profile. This targeted approach greatly reduces the risk of adverse reactions, ensuring a safer and more effective transfusion process. Adverse reactions to blood transfusions can range from mild discomfort to life-threatening complications. With personalized blood products, the risk of immune reactions, such as hemolytic transfusion reactions, can be significantly minimized. By aligning the genetic compatibility of donor and recipient, the likelihood of negative responses is greatly reduced, ultimately enhancing patient safety, and improving overall outcomes. The integration of genomics into blood collection is pioneering a new era where customization and precision are paramount. Laboratories equipped with advanced genetic testing capabilities can analyze the genetic markers that determine blood compatibility. This information is then used to match donors with recipients in a way that minimizes the potential for incompatibility-related complications.

Segmental Insights

Collection Site Insights

In 2023, the blood collection market was dominated by the venous segment and accounted for largest share in the market and is anticipated to continue expanding over the coming years. The primary factors influencing the growth of the venous segment are the rise in the demand for medical equipment for detection and diagnosis as well as the number of surgical procedures. The market is also rising as a result of increased knowledge of the benefits of venous blood collection devices over alternative techniques. The major advantage of these devices is that they are comparably painless and just need a minimal amount of blood for the treatment. Due to factors including the lower blood samples requirement, which reduces the danger of contamination, along with the rising research & development to create a wide range of innovative products, the capillary segment is predicted to experience the quickest growth rate during the forecast period.

End-Use Insights

In 2023, the blood collection market has seen the dominance of the hospitals segment, and this trend is expected to persist and even expand in the foreseeable future. Hospitals have historically been the primary locations for blood collection activities due to their central role in healthcare delivery and their ability to handle a wide range of medical procedures. As the prevalence of chronic diseases continues to rise globally, there is a corresponding increase in the demand for diagnostic and screening procedures, which further drives the need for blood collection services within hospital settings. Advancements in blood collection technology have led to improved efficiency, safety, and patient comfort, making it more convenient for hospitals to collect and process blood samples. This includes the development of innovative devices and techniques for venipuncture, as well as the implementation of automated systems for sample handling and processing.

The growing demand for blood products, such as red blood cells, platelets, and plasma, is driving hospitals to expand their blood collection capabilities. Blood transfusions are essential for various medical treatments, including surgeries, trauma care, cancer therapy, and organ transplants. Therefore, hospitals need to maintain adequate stocks of blood products to meet the needs of their patients, leading to increased collection efforts. Changing regulatory requirements pertaining to blood safety and quality assurance also play a significant role in shaping the hospitals segment of the blood collection market. Healthcare authorities worldwide impose strict regulations to ensure the safety and integrity of blood products, including screening for infectious diseases and proper handling procedures. Hospitals must comply with these regulations, which often necessitate investments in infrastructure, staff training, and quality control measures.

Regional Insights

The North America region has emerged as the frontrunner in the Global Blood Collection Market, solidifying its position through various factors contributing to its sustained growth and dominance. One of the primary drivers fueling this market supremacy is the surge in traffic accidents and the prevalence of chronic diseases across the region. The incidence of traffic accidents in North America has been on the rise in recent years, resulting in a greater demand for blood collection products and services. Traumatic injuries sustained in accidents often necessitate immediate blood transfusions to save lives, thereby driving the need for efficient blood collection and storage systems. The region's aging population, coupled with lifestyle factors, has led to an increased prevalence of chronic diseases such as cardiovascular disorders, cancer, and diabetes. These conditions often require regular blood tests and monitoring, further contributing to the demand for blood collection services.

North America boasts a robust healthcare infrastructure with advanced medical facilities and well-established blood collection centers. The presence of state-of-the-art laboratories equipped with cutting-edge technologies facilitates efficient blood collection, processing, and storage procedures. Additionally, the region is home to several leading players in the blood collection market, fostering a competitive landscape and driving innovation in product development and service offerings. Government initiatives and healthcare policies also play a significant role in shaping the blood collection market in North America. Regulatory bodies such as the Food and Drug Administration (FDA) ensure adherence to stringent quality standards and safety regulations, instilling confidence among consumers and healthcare providers alike. Government-sponsored initiatives aimed at increasing awareness about blood donation and promoting voluntary donation drives contribute to the availability of blood products for medical purposes.

Key Market Players

NIPRO Medical Corporation

Abbott Laboratories Inc.

Becton, Dickinson and Company

Terumo Corporation

Qiagen N.V

Medtronic plc

FL Medical s.r.l.

SARSTEDT AG & Co. KG

Greiner Holding AG

Haemonetics Corporation

Report Scope:

In this report, the Global Blood Collection Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Collection Market, By Collection Site:

    Venous
    • Needles & Syringes
    • Blood collection Tubes
    • Blood Bags
    • Others
    Capillary
    • Lancets
    • Micro-Container Tubes
    • Micro-Hematocrit Tubes
    • Warming Devices
    • Others

Blood Collection Market, By Application:

    Diagnostics Treatment

Blood Collection Market, By Method:

    Manual Automated

Blood Collection Market, By End-use:

    Hospitals Blood Banks Others

Blood Collection Market, By Region:

    North America
    • United States
    • Canada
    • Mexico
    Asia-Pacific
    • China
    • India
    • South Korea
    • Australia
    • Japan
    Europe
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
    South America
    • Brazil
    • Argentina
    • Colombia
    Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Collection Market.

Available Customizations:

Global Blood Collection Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Collection Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Collection Site (Venous {Needles and Syringes, Blood collection Tubes, Blood Bags, Others}, Capillary {Lancets, Micro-Container Tubes, Micro-Hematocrit Tubes, Warming Devices, Others})
    • 5.2.2. By Application (Diagnostics, Treatment)
    • 5.2.3. By Method (Manual, Automated)
    • 5.2.4. By End-use (Hospitals, Blood Banks, Others)
    • 5.2.5. By Company (2023)
    • 5.2.6. By Region
  • 5.3. Market Map

6. North America Blood Collection Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Collection Site
    • 6.2.2. By Application
    • 6.2.3. By Method
    • 6.2.4. By End-use
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Blood Collection Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Collection Site
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Method
        • 6.3.1.2.4. By End Use
    • 6.3.2. Mexico Blood Collection Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Collection Site
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Method
        • 6.3.2.2.4. By End Use
    • 6.3.3. Canada Blood Collection Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Collection Site
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Method
        • 6.3.3.2.4. By End Use

7. Europe Blood Collection Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Collection Site
    • 7.2.2. By Application
    • 7.2.3. By Method
    • 7.2.4. By End-use
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Blood Collection Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Collection Site
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Method
        • 7.3.1.2.4. By End Use
    • 7.3.2. Germany Blood Collection Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Collection Site
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Method
        • 7.3.2.2.4. By End Use
    • 7.3.3. United Kingdom Blood Collection Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Collection Site
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Method
        • 7.3.3.2.4. By End Use
    • 7.3.4. Italy Blood Collection Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Collection Site
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Method
        • 7.3.4.2.4. By End Use
    • 7.3.5. Spain Blood Collection Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Collection Site
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Method
        • 7.3.5.2.4. By End Use

8. Asia-Pacific Blood Collection Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Collection Site
    • 8.2.2. By Application
    • 8.2.3. By Method
    • 8.2.4. By End-use
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Blood Collection Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Collection Site
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Method
        • 8.3.1.2.4. By End Use
    • 8.3.2. India Blood Collection Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Collection Site
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Method
        • 8.3.2.2.4. By End Use
    • 8.3.3. South Korea Blood Collection Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Collection Site
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Method
        • 8.3.3.2.4. By End Use
    • 8.3.4. Japan Blood Collection Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Collection Site
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Method
        • 8.3.4.2.4. By End Use
    • 8.3.5. Australia Blood Collection Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Collection Site
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Method
        • 8.3.5.2.4. By End Use

9. South America Blood Collection Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Collection Market Site
    • 9.2.2. By Application
    • 9.2.3. By Method
    • 9.2.4. By End-use
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Blood Collection Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Collection Site
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Method
        • 9.3.1.2.4. By End Use
    • 9.3.2. Argentina Blood Collection Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Collection Site
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Method
        • 9.3.2.2.4. By End Use
    • 9.3.3. Colombia Blood Collection Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Collection Site
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Method
        • 9.3.3.2.4. By End Use

10. Middle East and Africa Blood Collection Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Collection Market Site
    • 10.2.2. By Application
    • 10.2.3. By Method
    • 10.2.4. By End-use
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Blood Collection Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Collection Site
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Method
        • 10.3.1.2.4. By End Use
    • 10.3.2. Saudi Arabia Blood Collection Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Collection Site
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Method
        • 10.3.2.2.4. By End Use
    • 10.3.3. UAE Blood Collection Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Collection Site
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Method
        • 10.3.3.2.4. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. NIPRO Medical Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Abbott Laboratories Inc.
  • 15.3. Becton, Dickinson and Company
  • 15.4. Terumo Corporation
  • 15.5. Qiagen N.V
  • 15.6. Medtronic plc
  • 15.7. FL Medical s.r.l.
  • 15.8. SARSTEDT AG & Co. KG
  • 15.9. Greiner Holding AG
  • 15.10. Haemonetics Corporation

16. Strategic Recommendations

17. About Us & Disclaimer